Clinical precision.
Measurable longevity.
LONVÉ Health is an AI-powered longevity intelligence practice for adults serious about healthspan. We run a 45-marker diagnostic panel, decode it with our proprietary biomarker engine against evidence-based optimal ranges, and our physicians prescribe precision peptide and lifestyle protocols — then re-baseline your biology quarterly to verify the protocol is working.
Four steps. Every one supervised by a physician.
We do not prescribe based on questionnaires alone. Every recommendation begins with objective laboratory data and ends with a clinician's signature.
A structured medical history captures symptoms, medications, family history, and goals — the same data your physician would gather in person.
45 markers across glycemic, cardiovascular, hormonal, inflammatory, thyroid, and micronutrient domains. Performed at any LabCorp or Quest location, or via mobile phlebotomy.
A 30-minute video consult with a licensed physician. Results are reviewed line-by-line, candidate protocols are discussed, and a written care plan is finalized.
Repeat panel at 90 days to verify response. Protocols are adjusted, escalated, or de-escalated based on objective change — not assumption.
45 markers. Seven physiological systems.
Our panel reflects the standard of care used in academic longevity medicine — including ApoB and Lp(a) for cardiovascular risk stratification, HOMA-IR for early insulin resistance, RBC magnesium and omega-3 index for tissue-level micronutrient status, and TPO antibodies for autoimmune thyroid screening.
FDA-approved, compounded, and investigational — categorized honestly.
We do not claim every peptide is proven. Our library lists FDA-approved therapies, compounded peptides with mechanistic and animal evidence, and investigational molecules separately — so you and your physician make informed decisions.
GHRH(1-29) analog. Stimulates endogenous, pulsatile growth-hormone release from the anterior pituitary.
- →Restoration of physiologic GH/IGF-1 rhythm
- →Improved sleep architecture (slow-wave)
- →Lean body mass support
Dual GIP/GLP-1 receptor agonist. Greater weight-loss efficacy than mono-agonists.
- →~20–22% body-weight reduction (SURMOUNT-1)
- →Superior glycemic control vs semaglutide (SURPASS-2)
Pentadecapeptide derived from gastric juice. Promotes angiogenesis (VEGFR-2), tendon-to-bone healing, gut mucosal repair.
- →Soft-tissue and tendon repair
- →Gut lining integrity
- →Reduced local inflammation
Mitochondrial-derived 16-aa peptide. Activates AMPK, improves insulin sensitivity, and supports mitochondrial biogenesis.
- →Improved insulin sensitivity (preclinical)
- →Exercise-mimetic effects
- →Metabolic flexibility
28-aa thymic peptide. Promotes T-cell maturation and Th1 polarization.
- →Adjunct in chronic hepatitis B/C
- →Immune support in immunosenescence
- →Investigational in sepsis
Cardiolipin-binding tetrapeptide that stabilizes the inner mitochondrial membrane and restores ATP production.
- →Mitochondrial efficiency
- →Investigational in primary mitochondrial myopathy and heart failure
Patient M., 47 · Cardiometabolic drift, low GH axis
A composite case used to illustrate how the panel informs a protocol. Not a real patient.
Illustrative only. Final dosing, eligibility, contraindications, and monitoring schedule are determined by a licensed physician after a complete clinical evaluation.
Internal medicine. Endocrinology. Functional longevity.
Our clinicians are U.S. board-certified physicians with additional training in preventive cardiology, endocrinology, or sports medicine. AI assists with pattern recognition; physicians make every clinical decision.
- Licensed in all 50 U.S. states and select EU jurisdictions
- 30-minute video consultation within 72 hours of lab results
- Direct secure messaging with your assigned physician
- Quarterly diagnostic re-evaluation included in every membership
- No conflict-of-interest pharmacy ownership
Documented change. Honest expectations.
Reviews are collected by Trustpilot after each completed quarterly cycle. We do not edit or curate — only verified patients can submit.
Six months in, my HbA1c moved from 5.9 to 5.3 and my ApoB is finally under 80. My clinician walked me through every change before we made it. Nothing about this felt rushed or oversold.
Perimenopause was wrecking my sleep and energy. The panel showed exactly why — low progesterone, suboptimal thyroid, ferritin in the basement. The protocol was modest but the difference is real and measurable.
A shoulder injury I'd had for two years finally resolved on a structured BPC-157 / TB-500 course alongside physiotherapy. My hs-CRP dropped from 4.1 to 0.9 along the way. The clinician explained every evidence gap openly.
As a physician myself, what convinced me was the rigor. They cited the papers, flagged what wasn't well-evidenced, and refused to prescribe things outside guidelines. That's medicine, not wellness theatre.
My GP had been tracking LDL for a decade and missing the actual picture. LONVÉ ran ApoB and Lp(a) on the first visit, started a statin plus lifestyle change, and re-tested at 90 days. ApoB down 38 points.
Lab logistics took two weeks longer than I hoped (timing was on me, not them). Once the panel was in, the consult was outstanding — 45 minutes, no upsell, clear written plan. The follow-up cadence is what's keeping me on track.
I came in expecting a long peptide stack. They told me my single biggest lever was vitamin D and sleep, started there, re-tested, and only then layered in tesamorelin once we had baseline data. Honest sequencing.
My TSH was 'normal' but my TPO antibodies were 410. No one had ever run them. LONVÉ flagged it on the first review, referred me to an endocrinologist, and built a supportive nutrition and selenium plan. Game changer.
Reviews shown are illustrative for this demo build. In production, individual results vary and depend on baseline status, adherence, comorbidities, and other factors. No clinical outcome is guaranteed.
Direct answers.
Anything else? The LONVÉ Concierge is available 24/7 in the corner of every page.
Is peptide therapy safe?+
Safety depends entirely on the specific peptide, dose, route, your medical history, and clinical monitoring. FDA-approved peptides (e.g. semaglutide, tirzepatide, tesamorelin, bremelanotide) have extensive safety data. Compounded peptides have variable evidence — we tell you exactly what is known and not known for each one. We will not prescribe outside a physician's evidence-based judgment.
Are peptides legal?+
It varies. Several peptides on our library are FDA-approved. Others are available only via state-licensed 503A/503B compounding pharmacies, and some are restricted to research use only. In September 2023, the FDA placed BPC-157 and several others on its restricted compounding list. LONVÉ Health prescribes only what is currently legal in your specific state or country.
How much does the program cost?+
The 45-marker LONVÉ diagnostic panel, AI report, and 30-minute physician consultation is $549 (introductory). Quarterly membership including re-testing and clinician access is $189/month. Compounded medications and pharmacy fees are billed separately by the pharmacy.
Can I use my own recent labs?+
Yes. We accept PDFs from any major laboratory (LabCorp, Quest, Medichecks, Randox, Vibrant) drawn within the last six months. Our system parses values automatically and flags any markers missing from our panel.
Does the AI assistant give medical advice?+
No. The LONVÉ AI Concierge explains markers, peptides, and our clinical workflow in plain language. It cannot diagnose, prescribe, or replace your physician. Every clinical decision is made by your assigned LONVÉ physician.
What happens if a protocol isn't working?+
We re-evaluate at 90 days using objective lab change. If a marker has not moved as expected, your physician adjusts dose, switches the molecule, adds adjunct therapy, or de-prescribes. We do not maintain protocols that aren't producing measurable change.
LONVÉ Health does not provide medical advice through this website. All content — including the AI Concierge, the assessment tool, protocol previews, and educational material — is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition.
Peptide therapies are initiated only after a complete clinical intake, laboratory analysis, and formal acceptance of the patient by a LONVÉ-affiliated licensed physician, and only in jurisdictions where the specific therapy is legally available. Several peptides discussed are investigational, have limited or no human trial data, or are subject to evolving regulatory restriction (including the FDA's September 2023 compounding restriction list). Inclusion in our library does not imply endorsement, efficacy, or safety for any individual patient.
If you think you may have a medical emergency, call your local emergency services immediately.